Diclofenac Sodium Topical Solution recalled for defective container
Teligent Pharma, Inc. is recalling Diclofenac Sodium Topical Solution USP 1.5% w/w due to a defective container. The recall affects approximately 2,664 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a defective container rather than a contamination or stability issue with direct reports of harm. No illnesses, injuries, or hospitalizations are reported in the source text, and the hazard is defect-related rather than a high-risk pathogen or allergen issue.
Plain-English summary
Teligent Pharma, Inc. is recalling Diclofenac Sodium Topical Solution USP, 1.5% w/w, 5 fl oz (150 mL) plastic bottles (NDC 52565-002-05) due to a defective container. Lot #15188 with an expiration date of February 2023 is affected by this recall.
The defective container poses a risk to product integrity and safety. Approximately 2,664 bottles were distributed nationwide in the United States.
Healthcare providers and patients who have this medication should stop using it and contact their pharmacy or healthcare provider for guidance on obtaining a replacement or alternative medication. Patients should not discontinue their diclofenac therapy without medical advice.
The recalled product
- Product
- Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 52565-002-05
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical anti-inflammatory
- Affected units
- 2,664
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 15188
- Exp 2/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · defective container
See all →- High
- ModeratePureLife benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateBurkhart benzocaine topical anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModeratePearson Quality benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24
- ModerateDental City benzocaine anesthetic gel bottles may have incomplete seals
FDA (Drugs) · 2026-06-24